WG2. Functional Biology
Leadership

Chris Lord
ICR LONDON

Patrick Derksen
UMC UTRECHT

Clair Turner
PA (UK), LBCUK
Participants
Beatrice | Howard | Institute of Cancer Research |
Cathrin | Brisken | EPFL/ICR |
Christopher | Lord | Institute of Cancer Research |
Christine | Desmedt | KU Leuven |
Claire | Turner | Lobular Breast Cancer UK |
David | Spector | CSHL |
George | Sflomos | EPFL |
Georgios | Skiadas | Institute of Cancer Research |
Minakshi | Gandhi | CSHL |
Patrick | Derksen | UMC Utrecht |
Renee | Flaherty | Institute of Cancer Research |
Sankari | Nagarajan | The University of Manchester |
Santiago | Madera | Institute of Cancer Research |
Syed | Haider | Institute of Cancer Research |
Thurkaa | Shanmugalingam | King’s College London |
Val | Brunton | Edinburgh Cancer Centre |
William | Yang | ICR |
Yanbo | Liu | Institute of Cancer Research |
Past and Future meetings
START-UP NEW FB WG (Online, Feb 24rd, 2025)
Leadership meeting to mark the start of the new WG “functional Biology”
MODELS MEETING (Utrecht, October 12-13, 2023)
Strategic Alignment meeting @ UMC Utrecht.
Activities
The Functional Biology Working Groups (formerly the Models WG) represents a close-nit group that has been productive from the start of the ELBCC in 2018. They have published a seminar paper, a Tour de Force first-authored by Georgios Flomos (EFPL) in which the current state of affairs were culminated in the ATLAS OF LOBULAR BREAST CANCER MODELS.
Click on the image to download the paper as PDF.
Members from the UMC Utrecht (Derksen lab) have published a paper in THE JOURNAL OF PATHOLOGY showing that Afadin (AFDN), represents a new ILC invasion suppressor. They show that Afadin confers invasion suppression through stabilization of the E-cadherin to F-actin link through the α-catenin binding CC domain.